Publications by authors named "Lamonde Frederic"
Background: Socioeconomic status (SES) is a driver of health disparities and chronic diseases. People with HIV (PWH) are at risk for chronic liver diseases. We evaluated the association between low SES and hepatic outcomes in PWH.
View Article and Find Full Text PDFArticle Synopsis
- The study investigated the effectiveness of combining sunitinib, an antiangiogenic agent, with radiotherapy and temozolomide for treating newly diagnosed glioblastoma (GBM) patients with an unmethylated O6-methylguanine-DNA-methyltransferase (MGMT) promoter.
- Patients exhibited a median progression-free survival of 7.15 months and a median overall survival of 15 months, with certain factors like more adjuvant cycles and lower neutrophil-to-lymphocyte ratios significantly improving outcomes.
- Safety concerns arose, with notable side effects such as thrombocytopenia and neutropenia, but no grade 5 toxicity events were reported, suggesting some promise for this treatment combination in future
Objective: Most fear of cancer recurrence (FCR) interventions have small effects, and few target FCR. This randomized controlled trial (RCT) with breast and gynecological cancer survivors evaluated the efficacy of a cognitive-existential fear of recurrence therapy (FORT) compared to an attention placebo control group (living well with cancer [LWWC]) on FCR.
Method: One hundred and sixty-four women with clinical levels of FCR and cancer distress were randomly assigned to 6-weekly, 120 min FORT (n = 80) or LWWC (n = 84) group sessions.
Background: COVID-19 affected healthcare worldwide, limited access to healthcare, and delayed cancer screening and diagnosis. In this study, the effect of the first year of COVID-19 was determined on cancer diagnoses in the province of Quebec, Canada.
Methods: Data were collected from the 13 Quebec Cancer Registry health institutions.